Actinium Pharmaceuticals, Inc. ATNM
Set alert
1.43 USD 0.00 0.00%
As of Nov 3, 12:45 PM ET
1.42 Day range 1.46
0.735 52-week range 1.72
- YTD
- +5.15%
- 1 year
- +3.62%
- Open
- 1.40
- Prev close
- 1.43
- Mkt cap
- 44.96M
- Vol
- 24.94K
- Avg vol
- 187.48K
- EPS
- 0.36
- P/E
- 3.97
- Div yield
- 0.00%
More statistics
- Low
- 1.42
- High
- 1.46
- Forward P/E
- -1.77
- Beta
- 0.15
- Short ratio
- 5.72
- Inst. own
- 30.11%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.55
- 200-d avg
- 4.86
- 1y target
- 5.00
Analyst view
Price target (mean) 5.00 +249.7% upside
Now 1.43
- Target (low)
- 2.00
- Target (mean)
- 5.00
- Target (high)
- 9.00
Ratings (0m) 5 4 buy · 1 hold · 0 sell
- Strong buy2
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.39 | -0.44 – -0.29 | -0.33 | -18.2% | 0 | -100.0% | 4 |
| Next quarter | -0.41 | -0.41 – -0.41 | -0.31 | -32.3% | 0 | 0.0% | 1 |
| Current year | -1.43 | -1.50 – -1.24 | -1.83 | +22.1% | 0 | -100.0% | 4 |
| Next year | -0.6575 | -1.28 – 0.16 | -1.43 | +53.9% | 14.74M | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 19, 2024 | Stephens & Co. | Reiterated | Overweight | Overweight |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 6, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 6, 2024 | Maxim Group | Maintained | Buy | Buy |
| Jul 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 17, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 21, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 14, 2024 | Stephens & Co. | Initiated | — | Overweight |
| May 2, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 30, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Apr 29, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 1, 2024 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Mar 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 19, 2024 | Maxim Group | Maintained | Buy | Buy |
| Mar 19, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 11, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 11, 2023 | B. Riley Securities | Maintained | Buy | Buy |
| Oct 3, 2023 | B. Riley Securities | Reiterated | Buy | Buy |
| Sep 7, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 6, 2023 | HSBC | Initiated | — | Buy |
| Aug 15, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 16, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 20, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
